Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

XERS holding history

Xeris Biopharma Holdings, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XERS overviewAll 13F holders of XERSFull Q2 2026 holdings

Shares (Q2 2026)
28,115
Value
$222.7K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of XERS by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,115$222.7K<0.1%−2,365−7.8%ReducedHolders
Q1 202630,480$176.8K<0.1%−4,910−13.9%ReducedHolders
Q4 202535,390$277.8K<0.1%+3,383+10.6%AddedHolders
Q3 202532,007$260.5K<0.1%−4,716−12.8%ReducedHolders
Q2 202536,723$171.5K<0.1%−358−1.0%ReducedHolders
Q1 202537,081$203.6K<0.1%−9,472−20.3%ReducedHolders
Q4 202446,553$157.8K<0.1%−24,051−34.1%ReducedHolders
Q3 202470,604$201.2K<0.1%+43,630+161.7%AddedHolders
Q2 202426,974$60.7K<0.1%−6,614−19.7%ReducedHolders
Q1 202433,588$74.2K<0.1%+2,739+8.9%AddedHolders
Q4 202330,849$72.5K<0.1%+4,537+17.2%AddedHolders
Q3 202326,312$48.9K<0.1%+122+0.5%AddedHolders
Q2 202326,190$68.6K<0.1%+1,179+4.7%AddedHolders
Q1 202325,011$40.8K<0.1%+25,011NewHolders
Q4 20220$00.0%−26,029−100.0%Sold outHolders
Q3 202226,029$41.0K<0.1%+601+2.4%AddedHolders
Q2 202225,428$39.0K<0.1%+11,445+81.8%AddedHolders
Q1 202213,983$36.0K<0.1%−3,578−20.4%ReducedHolders
Q4 202117,561$51.0K<0.1%+3,356+23.6%AddedHolders
Q3 202114,205$35.0K<0.1%+2,280+19.1%AddedHolders
Q2 202111,925$49.0K<0.1%−8,539−41.7%ReducedHolders
Q1 202120,464$92.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.